ENG |

Syntekabio
Make Bio Seen

Ai Beyond Life
Science

Accelerating
Bio Innovation

Our AI-powered platforms accelerate the entire drug discovery process — enabling faster, more precise innovation across small molecules, antibodies, and cancer vaccines.

SM-ARS®

AI-based small-molecule drug discovery

AB-ARS®

AI-based antibody candidate discovery

NEO-ARS®

AI-based neoantigen discovery & vaccine design

DEEPMATCHER®

Language model for protein-compound interaction prediction

LM-VS™

Language Model-based Virtual Screening

AI Software

AI-Driven Drug Discovery Platform

Big Data

Language Model and STB Cloud

Supercomputing Power

AI Bio Supercom Center

Syntekabio in Numbers

Drug Discovery Acceleration
3x
Patent Portfolio
30
Global Partnerships
30
Korea AI Bio Supercomputing Center
1&Only

Latest News

Syntekabio Expects KRW 2 Billion Annual Revenue from Patented Data Center System

Eco-Friendly “Termite-Inspired” Data Center Design Receives Patent Registration

2025.09.02
# Syntekabio # Data Center # Patent

Syntekabio Sees Smooth Domestic & International Deals... Accelerated Revenue Growth with Next-Gen Platforms

Targeting next-generation markets with its antibody optimization and cancer vaccine discovery platforms

2025.08.27
# Syntekabio # NextGenPlatform # Biotech

Syntekabio Posts KRW 1.2 Billion Revenue in First Half of the Year

Over KRW 1.0 Billion in revenue generated from AI drug discovery platform DeepMatcher

2025.08.13
# Syntekabio # DeepMatcher # AI Drug Discovery

Research Highlights

View More
Academic

Nitrosylation of β2-Tubulin Promotes Microtubule Disassembly and Differentiated Cardiomyocyte Beating in Ischemic Mice, Tissue Engineering and Regenerative Medicine

Read More Academic

RDscan: A New Method for Improving Germline and Somatic Variant Calling Based on Read Depth Distribution, Journal of Computational Biology

Read More Academic

Biomarker LEPRE1 induces pelitinib-specifc drug responsiveness by regulating ABCG2 expression and tumor transition states in human leukemia and lung cancer, Scientific Reports (2022)

Read More Academic

Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway, OncoImmunology (2021)

Read More Academic

Pan-cancer analysis of whole genomes, Nature (2020)

Read More Academic

Butler enables rapid cloud-based analysis of thousands of human genomes, Nature Biotechnology (2020)

Read More Academic

Integrated genome sizing (IGS) approach for the parallelization of whole genome analysis, BMC Bioinformatics (2019)

Read More